Degron Therapeutics vs HistoSonics
Degron Therapeutics vs HistoSonics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Degron Therapeutics is on 62/100 and HistoSonics on 47/100.
Where each one leads
Degron Therapeutics
- our overall score: 62/100 against 47/100
HistoSonics
- agent readiness: 37/100 against 27/100
- domain rating: 48/100 against 24/100
- funding raised: $140M against $40.0M
At a glance
| Measure | Degron Therapeutics | HistoSonics |
|---|---|---|
| What it is | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. | Developing a new histotripsy therapeutic platform for cancer treatment. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare | Biotechnology, Medical Devices, HealthTech, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Hardware |
| Founded | 2020 | Not published |
| Headquarters | San Diego, USA | Minneapolis, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Degron Therapeutics | HistoSonics |
|---|---|---|
| Employees | 24 | Not published |
| Total funding | $40.0M | $140M |
| Latest round | Series A Extension | Funding Round |
| Valuation | $1.1B | $1.1B |
| LinkedIn followers | 1,380 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Degron Therapeutics | HistoSonics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 47/100 |
| Traction | Not published | 40/100 |
| Team | 24/100 | Not published |
| Search visibility | 57/100 | 5/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (27/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 24/100 | 48/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Degron Therapeutics | HistoSonics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager |
| Support stack | Not detected | HubSpot |
What users say
| Measure | Degron Therapeutics | HistoSonics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 4 positive, 0 negative across 6 threads |
“Tumor-destroying soundwaves receive FDA approval for liver treatment in humans. The US FDA has approved HistoSonics to market a liver cancer treatment using histotripsy, an ultrasound-based technology developed at the University of Michigan”r/STEW_ScTecEngWorld
Degron Therapeutics vs HistoSonics: common questions
Which is better, Degron Therapeutics or HistoSonics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Degron Therapeutics and HistoSonics compare on the numbers?
Degron Therapeutics leads on our overall score (62/100 against 47/100). HistoSonics leads on agent readiness (37/100 against 27/100), domain rating (48/100 against 24/100), funding raised ($140M against $40.0M).
What do real users say about Degron Therapeutics and HistoSonics?
HistoSonics: 4 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/STEW_ScTecEngWorld.
Read the full Degron Therapeutics review and pricing or the HistoSonics review and pricing. You can also browse other Degron Therapeutics alternatives we track.